Avantor, Inc. Interest Expense
Avantor, Inc. (AVTR) reported Interest Expense of $42.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-04-29
- Avantor, Inc. interest expense for the quarter ending 2026-03-31 was $42.90M, a 1.66% increase year-over-year.
- Avantor, Inc. interest expense for the quarter ending 2025-09-30 was $44.20M, a 9.24% decline year-over-year.
- Avantor, Inc. interest expense for the quarter ending 2025-06-30 was $43.40M, a 28.74% decline year-over-year.
- Avantor, Inc. interest expense for the quarter ending 2025-03-31 was $42.20M, a 34.37% decline year-over-year.
- Avantor, Inc. interest expense for fiscal 2023 was $284.80M, a 7.15% increase from fiscal 2022.
- Avantor, Inc. interest expense for fiscal 2022 was $265.80M, a 22.26% increase from fiscal 2021.
- Avantor, Inc. interest expense for fiscal 2021 was $217.40M, a 29.32% decline from fiscal 2020.
- Avantor, Inc. interest expense for fiscal 2020 was $307.60M, a 30.09% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $42.90M 10-Q · filed 2026-04-29 | |||
| 2025-09-30 | $44.20M 10-Q · filed 2025-10-29 | $87.60M derived: sum of 2 quarters · filed 2025-10-29 | $129.80M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $43.40M 10-Q · filed 2025-08-01 | $85.60M 10-Q · filed 2025-08-01 | ||
| 2025-03-31 | $42.20M 10-Q · filed 2026-04-29 | |||
| 2024-09-30 | $48.70M 10-Q · filed 2025-10-29 | $109.60M derived: sum of 2 quarters · filed 2025-10-29 | $173.90M 10-Q · filed 2025-10-29 | $239.20M derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | $60.90M 10-Q · filed 2025-08-01 | $125.20M 10-Q · filed 2025-08-01 | $190.50M derived: sum of 3 quarters · filed 2025-08-01 | $262.90M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $64.30M 10-Q · filed 2025-04-25 | $129.60M derived: sum of 2 quarters · filed 2025-04-25 | $202.00M derived: sum of 3 quarters · filed 2025-04-25 | $275.40M derived: sum of 4 quarters · filed 2025-04-25 |
| 2023-12-31 | $65.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $137.70M derived: sum of 2 quarters · filed 2024-10-25 | $211.10M derived: sum of 3 quarters · filed 2024-10-25 | $284.80M 10-K · filed 2024-02-14 |
| 2023-09-30 | $72.40M 10-Q · filed 2024-10-25 | $145.80M derived: sum of 2 quarters · filed 2024-10-25 | $219.50M 10-Q · filed 2024-10-25 | $289.30M derived: sum of 4 quarters · filed 2024-10-25 |
| 2023-06-30 | $73.40M 10-Q · filed 2024-07-26 | $147.10M 10-Q · filed 2024-07-26 | $216.90M derived: sum of 3 quarters · filed 2024-07-26 | $284.20M derived: sum of 4 quarters · filed 2024-07-26 |
| 2023-03-31 | $73.70M 10-Q · filed 2024-04-26 | $143.50M derived: sum of 2 quarters · filed 2024-04-26 | $210.80M derived: sum of 3 quarters · filed 2024-04-26 | $274.70M derived: sum of 4 quarters · filed 2024-04-26 |
| 2022-12-31 | $69.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $137.10M derived: sum of 2 quarters · filed 2024-02-14 | $201.00M derived: sum of 3 quarters · filed 2024-02-14 | $265.80M 10-K · filed 2024-02-14 |
| 2022-09-30 | $67.30M 10-Q · filed 2023-10-27 | $131.20M derived: sum of 2 quarters · filed 2023-10-27 | $196.00M 10-Q · filed 2023-10-27 | $256.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $63.90M 10-Q · filed 2023-07-28 | $128.70M 10-Q · filed 2023-07-28 | $189.50M derived: sum of 3 quarters · filed 2024-02-14 | $243.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $64.80M 10-Q · filed 2023-04-28 | $125.60M derived: sum of 2 quarters · filed 2024-02-14 | $179.70M derived: sum of 3 quarters · filed 2024-02-14 | $230.70M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $60.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $114.90M derived: sum of 2 quarters · filed 2024-02-14 | $165.90M derived: sum of 3 quarters · filed 2024-02-14 | $217.40M 10-K · filed 2024-02-14 |
| 2021-09-30 | $54.10M 10-Q · filed 2022-10-28 | $105.10M derived: sum of 2 quarters · filed 2022-10-28 | $156.60M 10-Q · filed 2022-10-28 | $212.40M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $51.00M 10-Q · filed 2022-07-29 | $102.50M 10-Q · filed 2022-07-29 | $158.30M derived: sum of 3 quarters · filed 2023-02-14 | $223.50M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $51.50M 10-Q · filed 2022-04-29 | $107.30M derived: sum of 2 quarters · filed 2023-02-14 | $172.50M derived: sum of 3 quarters · filed 2023-02-14 | $264.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $55.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $121.00M derived: sum of 2 quarters · filed 2023-02-14 | $213.10M derived: sum of 3 quarters · filed 2023-02-14 | $307.60M 10-K · filed 2023-02-14 |
| 2020-09-30 | $65.20M 10-Q · filed 2021-10-29 | $157.30M derived: sum of 2 quarters · filed 2021-10-29 | $251.80M 10-Q · filed 2021-10-29 | $349.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $92.10M 10-Q · filed 2021-07-30 | $186.60M 10-Q · filed 2021-07-30 | $284.60M derived: sum of 3 quarters · filed 2022-02-11 | $382.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $94.50M 10-Q · filed 2021-04-28 | $192.50M derived: sum of 2 quarters · filed 2022-02-11 | $290.80M derived: sum of 3 quarters · filed 2022-02-11 | $405.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $196.30M derived: sum of 2 quarters · filed 2022-02-11 | $311.40M derived: sum of 3 quarters · filed 2022-02-11 | $440.00M 10-K · filed 2022-02-11 |
| 2019-09-30 | $98.30M 10-Q · filed 2020-10-27 | $213.40M derived: sum of 2 quarters · filed 2020-10-27 | $342.00M 10-Q · filed 2020-10-27 | $477.10M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $115.10M 10-Q · filed 2020-07-29 | $243.70M 10-Q · filed 2020-07-29 | $378.80M derived: sum of 3 quarters · filed 2021-02-16 | $509.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $128.60M 10-Q · filed 2020-04-29 | $263.70M derived: sum of 2 quarters · filed 2021-02-16 | $393.90M derived: sum of 3 quarters · filed 2021-02-16 | $524.10M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $135.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $265.30M derived: sum of 2 quarters · filed 2021-02-16 | $395.50M derived: sum of 3 quarters · filed 2021-02-16 | $523.80M 10-K · filed 2021-02-16 |
| 2018-09-30 | $130.20M 10-Q · filed 2019-11-05 | $260.40M derived: sum of 2 quarters · filed 2019-11-05 | $388.70M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $130.20M 10-Q · filed 2019-08-06 | $258.50M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $200.90M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |